936091-26-8

GPTKB entity

Statements (23)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvalYear 2018
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode L01ED10
gptkbp:CASNumber gptkb:936091-26-8
gptkbp:developedBy gptkb:Pfizer
gptkbp:hasInChIKey QXJYYZQYKJYFMA-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C21H19FN6O2
gptkbp:hasSMILES CC1=NN2C(=N1)C3=C(C(=NC(=C3)N)N2C)C4=CC(=C(C=C4)F)C(=O)N
gptkbp:hasUNII 6Z5B6HVF6O
https://www.w3.org/2000/01/rdf-schema#label 936091-26-8
gptkbp:isALKInhibitor true
gptkbp:isROS1Inhibitor true
gptkbp:IUPACName (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4',3':4,5]pyrrolo[2,1-f][1,2,4]triazolo[1,5-c][1,3]benzoxazin-4(3H)-one
gptkbp:molecularWeight 406.42 g/mol
gptkbp:PubChem_CID gptkb:CHEMBL3544943
gptkb:DB12173
71587765
gptkbp:synonym gptkb:Lorlatinib
PF-06463922
gptkbp:usedFor treatment of non-small cell lung cancer
gptkbp:bfsParent gptkb:fedratinib
gptkbp:bfsLayer 7